Editorial: Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms

    Research output: Contribution to journalArticle

    1 Citation (Scopus)
    Original languageEnglish (US)
    JournalSurgery (United States)
    DOIs
    StateAccepted/In press - Jan 1 2018

    Fingerprint

    Neoadjuvant Therapy
    Peptide Receptors
    Pancreatic Neoplasms
    Radioisotopes
    Therapeutics

    ASJC Scopus subject areas

    • Surgery

    Cite this

    @article{10844c4994754119b6c5291dd3a4b40d,
    title = "Editorial: Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms",
    author = "Rodney Pommier",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1016/j.surg.2017.12.023",
    language = "English (US)",
    journal = "Surgery (United States)",
    issn = "0039-6060",
    publisher = "Mosby Inc.",

    }

    TY - JOUR

    T1 - Editorial

    T2 - Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms

    AU - Pommier, Rodney

    PY - 2018/1/1

    Y1 - 2018/1/1

    UR - http://www.scopus.com/inward/record.url?scp=85041592436&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85041592436&partnerID=8YFLogxK

    U2 - 10.1016/j.surg.2017.12.023

    DO - 10.1016/j.surg.2017.12.023

    M3 - Article

    C2 - 29422353

    AN - SCOPUS:85041592436

    JO - Surgery (United States)

    JF - Surgery (United States)

    SN - 0039-6060

    ER -